Catalyst Wire Dossier Catalyst Wire Dossier

Timolol ophthalmic solution 0.5%

Timolol
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Timolol ophthalmic solution 0.5%, covering 2015-05-14 to 2023-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]

See pricing